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Abstract 
Policies to promote research and development (R&D) are high on the government’s agenda. R&D 
and innovation are seen as key drivers of economic growth and important for raising UK 
productivity. This paper considers recent trends in UK R&D performance. We show that UK R&D 
is more internationalised than that of other G5 countries and is becoming increasingly so at a faster 
rate. A rising share of UK R&D is funded from abroad and UK firms are undertaking more of their 
R&D overseas. Using an international panel of countries, we show that R&D in one country 
responds to a change in the price in another ‘competitor’ country. This suggests that UK innovation 
policies could play an important role in determining whether increasingly footloose R&D locates in 
the UK or moves overseas.  
JEL classification: F2, H3, O3. 
I. INTRODUCTION 
There has been long-standing concern that the UK has not been performing well 
in terms of its innovative output. Policy-makers and academics have increasingly 
emphasised the importance of research and development (R&D) and innovation 
as engines of growth.
1 In the UK, there is concern that its productivity gap with 
other G5 countries may be linked to its poor R&D track record.
2 
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Recent policy discussion in the UK has focused on the extension of tax 
credits for R&D expenditure to all firms as a means of encouraging more R&D.
3 
The empirical evidence suggests that spillovers from R&D and innovation are 
localised,
4 so the UK will want to promote itself as a good location for 
‘footloose’ R&D. One particular issue is how an R&D tax credit would interact 
with the European Union (EU) State Aids rules. These could prohibit a tax credit 
that explicitly targeted R&D performed in the UK.
5 The government therefore 
faces a balancing act between addressing EU competition concerns and 
promoting R&D in the UK.  
The stakes in the R&D policy game appear to be rising, in part because UK 
R&D is becoming increasingly international, and so potentially more footloose. 
Before implementing any R&D policies, it is useful to gain some understanding 
of what lies behind recent trends in the UK’s poor technological performance. 
This paper uses unique data sources to shed light on these issues. We show the 
following: 
•  Total business expenditure on R&D (BERD) as a proportion of gross 
domestic product (GDP) has increased in other countries but remained static 
in the UK. 
•  The UK has a larger share of R&D funded from abroad than any other G5 
country. This share is also growing more rapidly than in other G5 countries. 
•  The share of R&D performed in the UK that is directly undertaken by 
foreign-owned firms has also risen from 1995 to 1999. 
•  Looking at the largest R&D-performing sector — pharmaceuticals — an 
increasing share of R&D by UK firms is being conducted abroad. 
These trends point to increasing internationalisation of R&D. This appears to be 
happening in all G5 countries, but is more progressed in the UK, which appears 
to have started internationalising R&D earlier and has proceeded at a faster rate.  
The next section outlines some of the main trends in the UK’s innovative 
performance and compares them with those of the other G5 countries. Section III 
documents the increasing internationalisation of R&D. Section IV uses data on 
an international panel of countries and shows that R&D in one country responds 
to a change in the tax price of doing R&D in another ‘competitor’ country. The 
final section considers the policy implications of these trends for the UK. An 
appendix describes our data sources. 
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II. TRENDS IN UK INNOVATIVE PERFORMANCE 
Figure 1 shows trends in gross expenditure on R&D (GERD) as a share of GDP 
over time in the G5 countries.
6 In the UK, it has been falling in almost every year 
over the last two decades. This trend has continued into the late 1990s, with the 
share of GDP devoted to R&D falling every year from 1993 until 1998. This is 
in contrast to other G5 countries, whose R&D shares have, in general, shown an 
upward trend (see Table 1 for numbers for the most recent years).  
FIGURE 1 
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Source: OECD, 1999a. 
 
TABLE 1 
Total R&D (GERD) as a Percentage of GDP 
Per cent 
  1981 1990 1995 1996 1997 1998 1999 
France  1.93 2.37 2.31 2.30 2.21 2.18   
Germany  2.43 2.75 2.26 2.26 2.29 2.29   
Japan  2.32 3.04 2.98 2.83 2.91 3.06   
UK  2.39 2.16 1.99 1.92 1.84 1.83   
USA  2.42 2.78 2.61 2.66 2.71 2.74 2.84 
Source: OECD, 1999a. 
 
                                                                                                                                    
6There is a break in the German R&D figures because of reunification in 1991. This makes it difficult to make 
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Germany only for the earlier period. In the graphs, we show two separate series. Comparisons pre- and post-
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FIGURE 2 
Breakdown of R&D by Who Funds It and Who Conducts It 
























These GERD figures can be broken down in two ways — by who conducts 
the R&D and by who funds the R&D. These need not be the same agent, as, for 
example, the government will often fund R&D conducted by the business sector. 
Figure 2 depicts the relationship between total GERD, the three main groups that 
conduct it and the three main groups that fund it. The breakdown of GERD by 
who conducts it is shown in Table 2, averaged over the period 1981–98. In all 
countries, business conducts the bulk of R&D. The proportion conducted by 
higher education is highest in Japan, and the amount conducted by government 
varies somewhat, with France having a notably higher proportion.  
Figure 3 shows that the proportion of GERD conducted by business 
enterprises has also shown a strong increase in France, Japan and the USA and a 
much slower increase in the UK.  
TABLE 2 
Breakdown of GERD by Who Conducts It, 1981–98 
  Business enterprises  Government  Higher education
a 
France 60.0  23.2  16.8 
Germany 69.9  13.8  16.5 
Japan 67.2  9.1  23.6 
UK 66.5  15.1  18.5 
USA 72.3  10.3  17.5 
aThis also includes a small residual category called the ‘private non-profit sector’. 
Source: OECD, 1999a. 
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FIGURE 3 























Source: OECD, 1999a. 
 
The breakdown of GERD by who finances it is shown in Table 3. In all 
countries except France, domestic industry is the single largest source of R&D 
financing. It is noticeable that, in the UK, a larger share is funded from overseas 
than in the other G5 countries. In France and the USA, a larger share is funded 
by the government, and much of this is related to heavy defence R&D 
expenditure. 
While all countries have experienced a cutback in government expenditure on 
R&D over the last 20 years (see Figure 4), this decline has been most dramatic in 
the UK, from 49 per cent in 1981 to 24 per cent in 1998. This reflects two major 
trends across all countries: there have been cutbacks in government-provided 
services, such as the military, and thus corresponding cuts in R&D expenditure; 
and there has been a move away from direct government spending towards more 
incentive-based mechanisms for funding R&D, such as tax credits.
7  
TABLE 3 
Breakdown of GERD by Who Funds It, 1981–98 
  Domestic industry  Government  Overseas 
France 44.3  48.2  6.6 
Germany 61.4  36.5  1.7 
Japan 69.3  21.1  0.1 
UK 48.3  36.9  11.2 
USA 55.8  41.2  n.a. 
Source: OECD, 1999a. 
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FIGURE 4 































Source: OECD, 1999a. 
 
As we saw above, a large share of R&D is both carried out and funded by 
business. This business-funded business-conducted R&D is often thought to be 
the main driver of economic growth in the short run. Governments’ R&D 
programmes often pursue strategic objectives such as defence or environmental 
aims or more basic research. These may be riskier and have more long-run 
growth effects, as suggested in studies on the returns to government and business 
R&D expenditure.
8 As such, the intensity of business R&D to GDP is of central 
importance. It is also the part of GERD that would be directly affected by a tax  
 
FIGURE 5 































Source: OECD, 1999a. 
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credit. Business-funded business-conducted R&D as a share of GDP has been 
approximately flat in the UK over the 1980s and 1990s, as shown in Figure 5. In 
comparison, other G5 countries have increased their shares of business-funded 
business-conducted R&D. Thus, even in the business component of R&D, the 
UK’s intensity growth rate lags behind those of the other G5 countries. 
R&D expenditure is one indicator of innovative activity. It is a measure of the 
inputs to the innovative process. Do other indicators present a similar picture? 
Figure 6 shows that the number of R&D personnel per 1,000 members of the 
labour force has also declined over time in the UK in a way not seen in other G5 
countries.  
An indicator of innovative output is patent counts. These provide a similar 
picture. Table 4 shows the proportion of all patents taken out in the US Patent 
and Trademark Office by the nationality of the innovator. We use data from the 
US Patent and Trademark Office because it is the main international patenting 
office, with most patents of any value being patented there. The patents data give 
details of the firm that owns the patent and also the location of the inventor. We 
can use these to look at the origin of patents. 
The proportion of patents originating in France declined by 26 per cent over 
the two decades and the proportion originating in Germany declined by 34 per 
cent. Japanese patenting activity in the USA has increased significantly over the 
time period, rising by 72 per cent. The proportion originating in the UK fell by 
the most, declining 39 per cent over the period. The USA still has the largest 
share, but it has declined as well, by 10 per cent over the period. The decline and 
subsequent levelling-out after 1994 in the UK are shown in Figure 7. 
FIGURE 6 
















Note: Data are not available for the USA. 
Source: OECD, 1999a. Fiscal Studies 
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TABLE 4 
Percentage of Patents Taken Out in the US Patent and Trademark Office, 
by Nationality 
 France  Germany  Japan  UK  USA 
1980  3.25  8.90 11.18 3.77 61.57 
1985  3.26  8.94 17.28 3.39 56.16 
1990  3.12  7.92 20.90 3.04 53.39 
1995  2.64  6.03 20.07 2.35 56.61 
1996  2.48  5.85 19.75 2.20 56.99 
1997  2.58  5.87 19.49 2.34 56.32 
1998  2.45  5.87 19.68 2.28 55.57 
1999  2.42  5.85 19.22 2.31 55.63 
       
% change, 
1980–99 
–26% –34% +72% –39% –10% 
Source: US Patent and Trademark Office (http://www.uspto.gov). 
 
FIGURE 7 
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Source: Compiled from US Patent and Trademark Office data. 
 
While none of these indicators is perfect, taken together they paint a picture 
of the UK lagging behind other G5 countries technologically. In the next section, 
we consider whether the internationalisation of R&D has played a role in 
explaining this decline in the UK.  
III. INTERNATIONALISATION OF UK INNOVATIVE ACTIVITY 
The analysis in the previous section described trends in the aggregate level of 
R&D and innovative activity by the geographic location of the activity. The first The Internationalisation of UK R&D 
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part of this section describes trends in the amount of UK R&D funded or 
conducted by foreign firms. UK firms also undertake innovative activity 
overseas. The second part of this section considers quantitative evidence from 
one industry — pharmaceuticals — on how important this is. 
1. R&D by Foreign Firms in the UK 
In this section, we use a unique data-set to look at business R&D undertaken in 
the UK. We use the micro data that underlie the annual Business Expenditure on 
Research and Development (BERD) survey undertaken by the Office for 
National Statistics (ONS) (see Data Appendix for details). This provides details 
of R&D expenditure in the UK at the firm level. We can break this down by its 
source of funding. In particular, we can examine whether R&D has been funded 
domestically or from abroad. We can also break the expenditure down by the 
nationality of the firm that does the R&D. The UK is notable amongst the G5 
countries for having a high and rising share of foreign-funded R&D, as shown in 
Figure 8. By 1998, 22 per cent of UK business R&D was funded from abroad. 
This compares with 11 per cent in France, 0.4 per cent in Japan and 2.7 per cent 
in Germany.
9 
In Table 5, we show the breakdown of UK business expenditure on R&D by 
source of funding. Not surprisingly, a higher proportion of BERD is funded by 
industry than of GERD (gross expenditure on R&D) — see Table 3. This   
 
FIGURE 8 























Note: Data are not available for the USA. 
Source: OECD, 1999a. 
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TABLE 5 
Breakdown of UK BERD by Source of Funding 
  Government EU  Own  Overseas Other 
1994  13.5 0.9 62.2  16.7 6.7 
1995  11.4 1.0 62.0  17.9 7.7 
1996  9.8 1.0 62.0  19.8 7.4 
1997  10.6 1.1 64.0  17.4 6.9 
1998  12.0 1.5 59.9  20.0 6.6 
1999  10.4 1.0 60.8  21.4 6.4 
Source: Authors’ calculations using BERD survey. Calculated from non-grossed-up sample; see Data Appendix 
for details. 
 
proportion has remained fairly stable over the six-year period shown in Table 5. 
Government funding of BERD has fallen slightly, while overseas funding has 
risen from 16.7 per cent to 21.4 per cent. 
As we saw in the previous section, R&D can be broken down by who funds it 
or by who conducts it. In the BERD survey, we also have information on the 
nationality of the firm that conducts the R&D. Therefore we can break down 
business R&D by the nationality of the firm conducting the R&D and by the 
source of funding. In the first column of Table 6, we show the proportion of 
BERD in the UK that is conducted by foreign-owned firms. This has increased 
from 29 per cent in 1994 to almost 35 per cent in 1999. The second column 
shows that between 23 and 34 per cent of BERD conducted by foreign-owned 
firms was funded from overseas. The final column shows the proportion of 
BERD conducted by domestic-owned firms that is funded from overseas. This 
has increased over the period 1994–99. 
We can break the BERD conducted by foreign-owned firms down by 
nationality. In Table 7, we do this for 1996. In the first column, we see that 68.5  
 
TABLE 6 
Relationship between Nationality of Firm and BERD Funding 
  Percentage of BERD 
conducted by foreign firms 
Percentage of BERD 
conducted by foreign firms 
funded from overseas 
Percentage of BERD 
conducted by domestic firms 
funded from overseas 
1994 29.3  23.3  11.7 
1995 28.3  30.5  10.2 
1996 31.4  34.3  10.4 
1997 31.9  29.6  10.9 
1998 31.2  31.1  14.9 
1999 34.5  33.5  14.2 
Source: Authors’ calculations using BERD survey. Calculated from non-grossed-up sample; see Data Appendix 
for details. The Internationalisation of UK R&D 
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TABLE 7 
Percentage of Activities Undertaken by Nationality of Owner, 1996 
  R&D Manufacturing 
   Employment  Value-added  Investment 
British  68.5 73.1 65.6 60.7 
North  American  17.1 13.3 20.6 20.3 
European Union  7.5  7.7  7.7  11.1 
Other  European  2.0 3.2 3.1 3.4 
Japanese  3.6 2.0 1.9 4.0
 
Other  foreign  2.3 0.7 1.0 1.3 
Notes: Employment, value added and investment percentages are calculated from a sample of the selected 
Annual Census of Production (ACOP) Respondents Database (ARD) data. European Union countries are 
Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, the Netherlands, Portugal and Spain. 
Sources: Employment, value added and investment — Griffith and Simpson (2001); R&D — authors’ 
calculations using BERD survey. 
 
per cent of BERD is conducted by British-owned firms. North-American-owned 
conduct around 17 per cent, EU-owned around 7.5 per cent, other European 
around 2 per cent, Japanese around 3.6 per cent and other foreign-owned around 
2.3 per cent. The final three columns compare these shares with the shares of 
these same nationalities in manufacturing employment, value added and 
investment.
10 We see that the distribution of R&D is similar to the distribution of 
employment, value added and investment between the nationalities of plant 
owners in the UK. One reason could be that R&D undertaken by foreign firms in 
the UK is usually associated with their production processes and plants, rather 
than as a stand-alone R&D laboratory. 
Looking at patenting activity, we also see that the high share of foreign-
funded and foreign-conducted R&D in the UK is mirrored by a high share of 
patents taken out in the US Patent and Trademark Office by foreign firms that 
state the UK as the location of the inventor. As an indicator of this, we tabulate 
in Table 8 the total number of patents over the period 1995–99 for the five 
largest UK-based patenting firms. Three of these — Kodak, US Philips Co. and 
IBM — are subsidiaries of US multinationals with research bases in the UK. 
To look at this further, we took the 50 largest patenting firms that are located 
in the UK and separated them into those that were UK-owned and those where 
the owner was a foreign firm. These two lines are plotted in Figure 9. Mirroring 
the story of R&D, we see a high and rising share of the patenting of UK   
 
                                                                                                                                    
10We are not able to break BERD down between manufacturing and non-manufacturing since many R&D 
facilities are labelled as research labs, which fall outside this classification. But since about 80 per cent of UK 
business R&D is undertaken in the manufacturing sector, comparing total R&D with the manufacturing sector 
figures seems appropriate. Fiscal Studies 
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innovative activity accounted for by foreign firms. Overall, this suggests that the 
UK research base is strongly multinational in nature and becoming increasingly 
so over recent years.  
R&D can also be broken down by the industry that undertakes it. To 
investigate this internationalisation issue further, we look in greater detail at the 
UK pharmaceuticals industry, which is one of the UK’s fastest-growing 
industries. By 1998, it carried out over 20 per cent of total business R&D in the 
UK, which is a larger share than in all other G5 countries, as shown in Figure 10. 
In common with the aggregate figures, Figure 11 shows that the proportion of 
UK-based R&D in the pharmaceuticals industry being funded by foreign firms is 
also increasing. Their share rose from 18 per cent in 1994 to 29 per cent in 1998. 
TABLE 8 
The Top Five UK-Based Patenting Firms during 1995–99 
Rank  Firm  Number of patents 
1
st Zeneca  374 
2
nd BT  285 
3
rd Kodak  236 
4
th  US Philips Co.  233 
5
th IBM  224 
Source: US Patent and Trademark Office (http://www.uspto.gov). 
 
FIGURE 9 












aNumber of patents taken out by foreign- and UK-owned companies in the top 50 patenting firms. 
Source: Compiled from US Patent and Trademark Office data. 
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FIGURE 10 
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Source: UK BERD survey. 
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FIGURE 12 





















Sources: UK BERD survey; Datastream. 
 
2. UK Firms’ R&D Abroad 
Parallel to the increasing share of UK-based R&D funded by overseas firms, 
there is an increasing share of R&D funded by UK firms taking place abroad in 
the pharmaceuticals industry. Figure 12 shows the total amount of worldwide 
spending by UK pharmaceuticals firms
11 and the amount spent in the UK. Total 
spending has increased from just over £2 billion in 1994 to £2.9 billion in 1998 
and nearly £3.3 billion in 1999. However, spending on R&D in the UK by the 
same firms has increased far less, moving from £1.1 billion in 1994 to only  
£1.3 billion in 1999.
12 This suggests that these firms are increasing their R&D 
spending in their overseas research labs at a faster pace than in the UK. This 
trend is corroborated in a recent paper by Serapio and Dalton (1999), which 
suggests that the share of foreign firms in US R&D is increasing. 
So, overall, the UK pharmaceuticals R&D is rapidly internationalising in both 
directions. UK firms are increasing their overseas research expenditures while 
foreign firms are increasing their R&D activities in the UK. 
IV. FOOTLOOSE R&D 
One possible explanation for R&D moving abroad is to take advantage of 
favourable tax breaks. Bloom, Griffith and Van Reenen (2001) show that R&D 
responds to changes in its own tax price, using data on a panel of countries. 
However, in a world where multinationals can choose amongst alternative 
                                                                                                                                    
11This group is the 15 largest UK-based pharmaceuticals firms. 
12The definition of R&D in company accounts differs somewhat from the GERD and BERD definitions. The Internationalisation of UK R&D 
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locations in which to conduct their R&D, it is not only the domestic user cost of 
R&D capital but also the user cost of R&D in other locations that may affect 
firms’ investment behaviour. As shown above, multinationals conduct R&D in 
several locations and may be able to shift R&D between these locations at low 
cost. One important question then becomes whether tax credits are leading to an 
increase in R&D conducted worldwide, or whether they signal a form of tax 
competition between countries for ‘footloose’ R&D. Is their main impact to 
increase total levels of R&D or just to change its location? 
One way to investigate this issue is to include a measure of the user cost of 
R&D in foreign locations (
f
it ρ ) as well as domestic ones (
d
it ρ ). The user cost of 
R&D is the minimum rate of return a firm needs to earn on its R&D to satisfy its 
shareholders. This is also commonly known as a firm’s investment hurdle rate. If 
there is an effect from the tax treatment of R&D in other countries on relocation 
decisions, one would expect the coefficient on 
f
it ρ  to be greater than zero. 
Consider a model where firms have the option of conducting R&D 
domestically or in a foreign location. We can derive an empirical specification to 








it e t f y r + + + + +   = ρ β ρ β β 2 1 0 , 
where 
d
it r  is logged domestic real R&D, yit is logged domestic real output, fi are 
country-specific fixed effects and tt are a full set of time dummies. 
If a fall in the domestic user cost of R&D increases domestic R&D, then we 
would expect to see β1 < 0. If a reduction in the user cost of R&D in the foreign 
country has a significant impact on relocating R&D from the domestic location 
to the foreign location, then we would expect β2 > 0. As the cost of doing R&D 
in the foreign location falls, firms would shift R&D there and do less R&D 
domestically. 
Constructing the relevant foreign R&D user cost is clearly a problem. In the 
results below, we have used a weighted average of the user cost of investing in 
R&D in the other countries, where the weights are the average amount of foreign 
direct investment (FDI) going to each country over the 11-year period 1982–92. 
The use of FDI as an indicator is theoretically appealing since, in most countries, 
firms can only benefit from R&D tax credits if they have taxable profits in that 
country against which they can offset the credit. 
                                                                                                                                    
13This empirical specification can be derived by generalising the first-order conditions from a one-factor CES 
(constant elasticity of substitution) production function — see Bloom, Griffith and Van Reenen (2001) for 
more details. Alternatively, given the presence of time dummies and a specification in logs, this could represent 
the second stage of a two-stage R&D budgeting decision. Fiscal Studies 
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We are concerned about the possible endogeneity of this user cost variable. 
That is, we are concerned that there might be an omitted variable, such as the 
interest rate, that affects R&D, which is our explanatory variable. If there is, it 
would mean that we were finding a spurious relationship between the two 
variables. To get around this problem, we use an instrumental variables (IV) 
estimator. We use the tax component of the R&D user cost as an instrument, 
arguing that this is predetermined. These IV equations pass a Wald test on their 
overidentifying moment restrictions.
14 
In Table 9, we regress the amount of R&D done in one country on its own 
domestic user cost and the foreign user cost using a within-groups IV estimator. 
In the static model in column 1, the domestic user cost is significant and 
negatively signed, while the foreign user cost is significant and positively signed. 
This suggests that domestic R&D and foreign R&D are substitutes and there may 
be some relocation in response to R&D tax incentives. One concern we might 
have about the specification in column 1 is that it does not include dynamics. 
Empirical work has shown that R&D is a very persistent series. The omitted  
 
TABLE 9 
Relocation of R&D for Tax Reasons 
Dependent variable: ln(R&D)  (1) (2) (3) 
Lagged ln(R&D)  —  0.885  0.854 
   0.044  0.052 
Ln(domestic user cost)  –0.429  –0.135  –0.153 
 0.133  0.059  0.067 
Ln(foreign user cost)  1.054  0.364  0.775 
 0.524  0.223  0.330 
Ln(output) 1.213  0.016  –0.016 
 0.337  0.162  0.174 
      
Long-run elasticity — domestic user cost    –1.180  –1.050 
(P value from Wald test)    (0.057)  (0.029) 
Long-run elasticity — foreign user cost    3.176  5.300 
(P value from Wald test)    (0.161)  (0.023) 
      
Country dummies  Yes  Yes  Yes 
Year dummies  Yes  Yes  Yes 
Number of observations  139  139  122 
Notes: Countries included in sample are Australia, Canada, France, Germany, Italy, Japan, the UK and the 
USA; the USA is excluded in column 3. The data run from 1979 to 1997. Instruments are current and lagged 
tax price of domestic R&D, current and lagged foreign user cost of R&D and once- and twice-lagged output; 
columns 2 and 3 use once- and twice-lagged R&D in addition. 
                                                                                                                                    
14See Bloom, Griffith and Van Reenen (2001) for further discussion of the econometrics. The Internationalisation of UK R&D 
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dynamics may be affecting our results. However, it should be noted that, with 
very persistent series, it can be difficult to obtain consistent estimates of the 
coefficients in a dynamic specification. 
We include a lagged dependent variable in column 2. The domestic user cost 
remains negative and significant, with an impact elasticity of around 0.14 and a 
long-run elasticity of 1.18. The foreign user cost remains positive but is now 
imprecisely estimated so is no longer significant. An additional concern we 
might have is that countries vary in their openness and thus in the extent to 
which changes in the foreign tax price will affect domestic R&D. In particular, 
the USA is a relatively closed economy,
15 so that one would expect its response 
to the foreign user cost to be much lower. In column 3, we have dropped the 
USA and we see an increased and significant long-run foreign user cost 
coefficient. We did not find this result when we dropped any other individual 
country. 
Overall, we interpret these results as suggesting that there is a positive 
relationship between the amount of R&D conducted in one country and the tax 
price of conducting R&D in its major FDI partners. This suggests that at least 
part of the explanation for the mobility of R&D could be the increasing 
generosity of tax subsidies to R&D that are on offer in many countries. 
V. SUMMARY AND POLICY IMPLICATIONS 
This paper has examined recent trends in R&D in the UK and compared them 
with those in other G5 countries. Overall, we see that there has been a worrying 
decline in the UK in the proportion of GDP that goes into R&D and innovation, 
as measured by a number of indicators. This decline is in part attributable to the 
decline in government spending. However, even focusing on business-conducted 
business-funded R&D, we still see a decline. There has also been an increasing 
tendency for R&D in the UK to be carried out by foreign firms. Mirroring this, 
UK firms in the highest-R&D-growth industry — pharmaceuticals — have been 
doing an increasing amount of their R&D abroad. 
Why do we see this internationalisation of R&D? Two reasons are commonly 
given. First, it may be that the incentives for R&D introduced by other countries 
(such as the USA, France and Canada) are changing the international allocation 
of R&D and that the UK is losing out. The empirical evidence given above on 
the effect of the R&D tax credit suggests some of the internationalisation of UK 
R&D abroad could be in response to the more generous treatment of R&D in the 
USA and other OECD countries. Hall and Van Reenen (1999) survey the 
evidence on the impact of R&D tax credits and conclude that their effect is 
significant. 
                                                                                                                                    
15The USA is a relatively closed economy in the sense that exports and imports account for only about 10 per 
cent of GDP. Fiscal Studies 
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A second explanation is that agglomeration economies and other externalities 
are becoming increasingly important. Firms choose to do R&D where it is most 
productive. The paper by Serapio and Dalton (1999) suggests that technology 
sourcing is a large part of the reason why firms are moving their R&D to the UK.  
What does all of this imply for policy? If increasing internationalisation is an 
indicator that R&D is becoming more footloose, then the response of firms to 
fiscal incentives, such as R&D tax credits, could be higher than previously 
estimated and increasing over time. If, on the other hand, R&D is becoming 
geographically more concentrated in a few key markets (mainly the USA), then 
this suggests policy should focus on promoting the early location of 
technological clusters in the UK. 
DATA APPENDIX 
The aggregate figures on R&D and R&D employment used in Section II come 
from the MSTI data-set (OECD, 1999a).  
The patenting figures come from the US Patent and Trademark Office 
(http://www.uspto.gov); see also Bloom and Van Reenen (2000).  
The breakdowns by nationality of owner come from the micro data 
underlying the BERD survey collected by the Office for National Statistics 
(ONS). Ownership data are sometimes missing; we do not include these 
observations. 
The data used in the econometric analysis in Section IV come from the 
ANBERD data-set, which contains business enterprise R&D at the industry level 
(OECD, 1999b). This corresponds to the Frascati definition and is drawn from 
surveys by member states. Output is taken from the STAN data-set, also 
produced by the OECD (1999c), which can be matched into the ANBERD data. 
The separation of R&D by source of finance is achieved by using the figures 
from the MSTI data-set (OECD, 1999a). Output and other non-R&D variables 
are deflated using the GDP deflators (OECD, 1999c). R&D expenditure is 
deflated by a weighted average composed of 50 per cent wages and 50 per cent 
GDP deflator to reflect its strongly wage-related input costs. See Bloom, Griffith 
and Van Reenen (2001) for more details. 
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